Novo Nordisk
NVO
NVO
528 hedge funds and large institutions have $10.5B invested in Novo Nordisk in 2016 Q2 according to their latest regulatory filings, with 49 funds opening new positions, 159 increasing their positions, 217 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
1% less funds holding
Funds holding: 534 → 528 (-6)
4% less funds holding in top 10
Funds holding in top 10: 25 → 24 (-1)
27% less repeat investments, than reductions
Existing positions increased: 159 | Existing positions reduced: 217
Holders
528
Holding in Top 10
24
Calls
$24.1M
Puts
$23.6M
Top Buyers
| 1 | +$132M | |
| 2 | +$93.1M | |
| 3 | +$84.7M | |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$38M |
| 5 |
WCM Investment Management
Laguna Beach,
California
|
+$24.2M |
Top Sellers
| 1 | -$147M | |
| 2 | -$127M | |
| 3 | -$49.2M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$21.4M |
| 5 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$16M |